Pfizer Increases 2006 Earnings Outlook
Pfizer Inc. on Thursday raised its earnings guidance for the year as it showcased its pipeline of new drugs and a new approach to dealmaking that it said should put about six new products a year on the market beginning in 2011.
CEO Jeff Kindler told analysts and investors gathered for a review of the world’s […]